At a glance
ClinicalIndex Comparison RecordN/ANot Yet Recruiting· 150 target
Drug / intervention
Social Renew +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Triple-blind, Placebo Controlled, Parallel Virtual Clinical Trial to Investigate the Efficacy and Safety of GenLabs' Social Renew on Improving Acne Symptoms and Skin Repair Among Healthy Adults
In Brief
A clinical study evaluating Social Renew and Placebo for Acne. Not yet recruiting, targeting 150 participants across 1 site.
Detailed Summary
The goal of this interventional clinical trial is to investigate the efficacy and safety of GenLabs' Social Renew on improving acne symptoms and skin repair among healthy adults. The main question\[s\] it aims to answer is: What is the difference in the change in acne symptoms as assessed by the Acne Quality of Life Questionnaire (ACNE-QoL) between GenLabs' Social Renew and placebo from baseline at Day 30.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne
CountriesCanada
CollaboratorsKGK Science Inc.
Timeline
N/ANot Yet Recruiting
2026
First PostedAug 2025
Enrollment StartJul 2026
TodayJul 2026
Primary CompletionSep 2026
First PostedAug 17, 2025
Enrollment StartJul 1, 2026
Primary CompletionSep 1, 2026
TodayJul 1, 2026
Enrollment to primary: 2 monthsPosted 10 months agoPrimary completion in 2 months
Interventions
Social Renewother
This group receives a cleanser, serum, and cream.
Placeboother
This group receives a cleanser, serum, and cream.